Navigation Links
Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile
Date:9/23/2010

titors 109

Chapter 8 Appendix 111

References 111

Abbreviations 111

Exchange rates 113

About Datamonitor 114

About Datamonitor Healthcare 114

Datamonitor consulting 114

Disclaimer 116

List of Tables

Table 1: Bayer Schering Pharma - PharmaVitae forecasts at a glance 8

Table 2: Bayer Schering Pharma quarterly sales ($m), Q408-Q409 19

Table 3: Bayer Schering Pharma future product milestones, 2010-12 29

Table 4: Bayer Schering Pharma product portfolio overview ($m), 2003-09 46

Table 5: Bayer Schering Pharma product portfolio overview ($m), 2009-15 49

Table 6: Bayer Schering Pharma prescription pharmaceutical sales by therapy area ($m), 2009-15 54

Table 7: Bayer Schering Pharma prescription pharmaceutical sales by geographic region ($m), 2009-15 57

Table 8: Bayer Schering Pharma launch portfolio overview ($m), 2009-15 60

Table 9: Bayer Schering Pharma core portfolio overview ($m), 2009-15 62

Table 10: Bayer Schering Pharma expiry portfolio overview ($m), 2009-15 64

Table 11: Bayer Schering Pharma prescription pharmaceutical sales by molecule type ($m), 2009-15 68

Table 12: Bayer Schering Pharma prescription pharmaceutical sales by source ($m), 2009-15 71

Table 13: Total Bayer Schering Pharma sales by business unit ($m), 2003-09 74

Table 14: Bayer Schering Pharma operating revenue/cost analysis ($m), 2003-09 77

Table 15: Bayer Schering Pharma operating cost ratio analysis (% of total revenues), 2003-09 79

Table 16: Bayer Schering Pharma operating cost ratio analysis (% of total revenues), 2009-15 81

Table 17: Bayer Schering Pharma operating revenue/cost analysis ($m), 2009-15 82

Table 18: Bayer Schering Pharma Key products overview 84

Table 19: Xarelto: overview 85

Table 20: Xarelto: sales forecast ($m), 2009-15 86

Table 21: Nexavar: overview 88

Table
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reportlinker Adds Genzyme Corporation: PharmaVitae Profile
2. Reportlinker Adds Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
3. Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets
4. Reportlinker Adds Actelion Ltd: PharmaVitae Profile
5. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
6. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
7. Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile
8. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
9. Reportlinker Adds The Impact of US Healthcare Reform on Pharma: Analyzing the Effects
10. Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010
11. Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- ... affects persons of all ages, but most commonly ... condition characterized by narrowing of the airways, leading ... the lungs come into contact with endogenous and ... of events, such as swelling of the airways, ...
(Date:9/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Valeant Pharmaceuticals International, will redeem all of the outstanding ... Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 (the " ... an irrevocable notice of redemption for the Notes. ... irrevocable notice of redemption with respect to the remaining ...
(Date:9/15/2014)... Sept. 15, 2014  Decision Resources Group,s ... 2014, finds that online information and other ... to differentiate their offering and support physicians. ... purchasing decisions rely on websites, mobile apps ... devices—and these physicians are looking to manufacturers ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3
... , LAWRENCEVILLE, N.J. , Feb. 16 ... announced today that Wayne S. Mulcahy , Ph.D., ... A wholly owned subsidiary of Princeton Pharma Holdings LLC, ... unique products in ophthalmology and orphan diseases. , ...
... , GLEN BURNIE, Md. , Feb. ... delivery provider of prescription medications and veterinary therapeutic and ... Health, opening up the full suite of Pfizer products ... Health is the world,s leader in the discovery, development ...
Cached Medicine Technology:Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2VetCentric Announces Partnership With Pfizer Animal Health 2
(Date:9/15/2014)... “Canada Gynecological Devices Market Outlook ... Canada Gynecological Devices market. The report provides value, ... and average prices (in US dollars) within market ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ... Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), ...
(Date:9/15/2014)... In order to provide predictability and safety, ... to quantify, define and model medical practice. Defined as ... of medical care. , The Journal of BioAcoustic Biology ... the non-profit Institute of BioAcoustic Biology, located in Albany, ... be much more than a measurement tool; math, as ...
(Date:9/15/2014)... Florida is now one of several states holding “no ... test could be forced to undergo a mandatory blood test. ... more people from drinking and driving. , Federal government ... breathalyzer refusal. The new law is aimed to lower this ... , the new Florida law requires people to take a ...
(Date:9/15/2014)... Dennis Thompson HealthDay Reporter ... The severe respiratory virus believed to have sickened hundreds ... now spread to the Northeast, health officials report. ... Friday more than a dozen cases of infection with ... with asthma. And on Saturday, the Connecticut Department ...
(Date:9/15/2014)... 15, 2014 (HealthDay News) -- Births of multiple babies ... death than singleton births, researchers report. The researchers ... vitro fertilization (IVF) could ease some of that burden. ... increased in tandem with births to older mothers and ... the University of New South Wales, Australia. Their ...
Breaking Medicine News(10 mins):Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:New DUI Law Makes Blood Tests Mandatory 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3
... California will simultaneously open their doors,Wednesday to Trick or ... SAN DIEGO, Oct. 30 It,s not every ... don,t often,see miniature witches and 3-foot-tall bumblebees, and little ... But at more,than 150 nursing homes in California this ...
... Va.SNM, the worlds largest society for molecular imaging and ... in Tuesdays Roll Call urging Congress to fund basic ... future discoveries. Support DOE funding for nuclear medicine research, ... provides news of legislative and political interest to Capitol ...
... good responses in almost half of patients, study found , ... axitinib shows promise for treating people with what,s known as ... typically have a poor response to drug treatment. , Axitinib ... endothelial growth factor receptors 1, 2 and 3. , ...
... Ohio, Oct. 30 STERIS Corporation,(NYSE: STE ) ... ended September 30, 2007. Fiscal 2008 second quarter revenues,increased ... the second,quarter of fiscal 2007, primarily driven by growth ... quarter net income was $16.0 million, or $0.25 per,diluted ...
... Inc.,(Pink Sheets: HRAL) announced that it has received additional ... International, Inc.,(NYSE: WMT ), to open their ninth ... Wal-Mart Store #3195 located at 1070 Major,Mackenzie Drive in ... #7 Unit Y006A in Markham will both officially open ...
... Oct. 30 Anthera Pharmaceuticals,Inc., a privately held ... diseases, today announced,that Donald J. Santel has been ... experience in transforming early biotech startups into,commercial stage ... our pipeline,and move A-002 into large scale Phase ...
Cached Medicine News:Health News:Halloween Events Bring Young and Old Together for a Ghoulish Good Time 2Health News:SNM ad urges congress to fund nuclear medicine research 2Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 10Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3Health News:Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors 2
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
... to bring efficiency and quality to routine ... superior technology of fluorescent flow cytometry with ... sampling or batch processing are easily accommodated ... in high volume laboratories. Fluorescent flow ...
... The iQ200 System incorporates the ... and the AUTION MAX™ AX-4280 Automated ... a fully integrated chemical and microscopic ... (APR™), a well trained neural network, ...
... UF-100 is designed to bring efficiency and ... It combines the superior technology of fluorescent ... analysis. Continuous sampling or batch processing ... streamlining sample processing in high volume laboratories. ...
Medicine Products: